Pacific Biosciences of California, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Pacific Biosciences of California, Inc. (PACB) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$356.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- Pacific Biosciences of California, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$356.00K.
- Pacific Biosciences of California, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$604.00K.
- Pacific Biosciences of California, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $42.00K.
- Pacific Biosciences of California, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $148.00K, a 92.87% decline year-over-year.
- Pacific Biosciences of California, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $35.00K, a 82.76% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $203.00K, a 95.93% decline from fiscal 2023.
- Pacific Biosciences of California, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $4.98M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$356.00K 10-Q · filed 2026-08-06 | -$960.00K 10-Q · filed 2026-08-06 | -$918.00K derived: sum of 3 quarters · filed 2026-08-06 | -$770.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$604.00K 10-Q · filed 2026-05-08 | -$562.00K derived: sum of 2 quarters · filed 2026-05-08 | -$414.00K derived: sum of 3 quarters · filed 2026-05-08 | -$528.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $190.00K derived: sum of 2 quarters · filed 2026-02-25 | $76.00K derived: sum of 3 quarters · filed 2026-08-06 | $35.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $148.00K 10-Q · filed 2025-11-06 | $34.00K derived: sum of 2 quarters · filed 2026-08-06 | -$7.00K 10-Q · filed 2025-11-06 | -$1.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$114.00K 10-Q · filed 2026-08-06 | -$155.00K 10-Q · filed 2026-08-06 | -$1.29M derived: sum of 3 quarters · filed 2026-08-06 | $790.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$41.00K 10-Q · filed 2026-05-08 | -$1.17M derived: sum of 2 quarters · filed 2026-05-08 | $904.00K derived: sum of 3 quarters · filed 2026-05-08 | $687.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $945.00K derived: sum of 2 quarters · filed 2026-02-25 | $728.00K derived: sum of 3 quarters · filed 2026-02-25 | $203.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $2.08M 10-Q · filed 2025-11-06 | $1.86M derived: sum of 2 quarters · filed 2025-11-06 | $1.33M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$217.00K 10-Q · filed 2025-08-07 | -$742.00K 10-Q · filed 2025-08-07 | ||
| 2023-12-31 | $4.98M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |